Smokers deprived of cigarettes for 72 h: Effect of nicotine patches on craving and withdrawal

Psychopharmacology

Volumn 164, Issue 2, 2002, Pages 177-187

  Teneggi, Vincenzo ^a   Tiffany, Stephen T ^b   Squassante, Lisa ^a   Milleri, Stefano ^a   Ziviani, Luigi ^a   Bye, Alan ^a  

^a GSK   (Italy)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Cortisol; Craving; Nicotine patch; Pulse rate; Smoking withdrawal symptoms

Indexed keywords

NICOTINE; PLACEBO;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; MALE; NICOTINE REPLACEMENT THERAPY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADULT; BLOOD PRESSURE; CARBON MONOXIDE; COTININE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; HYDROCORTISONE; MALE; NICOTINE; QUESTIONNAIRES; RANDOM ALLOCATION; SALIVA; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036908091     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1176-1     Document Type: Article

References (40)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th Edn. APA, Washington
2. Breslau N, Kilbey MM, Andreski P (1992) Nicotine withdrawal symptoms and psychiatric disorders: Finding from epidemiologic studies. Am J Psychol 149:464-469
3. Burton SM, Tiffany ST (1997) The effect of alcohol consumption on craving to smoke. Addiction 92:15-26
4. Carter BL, Tiffany ST (1999) Meta-analysis of cue reactivity in addiction research. Addiction 94:327-340
5. Carter BL, Tiffany ST (2001) The cue-availability paradigm: The effects of cigarette availability on cue reactivity in smokers. Exp Clin Psychopharmacol 9:183-190
6. Corrigall WA, Zack M, Eissenberg T, Belsito L, Scher R (2002) Acute subjective and physiological responses to smoking in adolescents. Addiction 96:1409-1417
7. Cox LS, Tiffany ST, Christen AG (2001) Evaluation of the brief questionnaire of smoking urges (QSU-Brief) in laboratory and clinical settings. Nicotine Tobacco Res 3:7-16
8. Curry SJ, Mc Bride CM (1994) Relapse prevention for smoking cessation. Review and evaluation of concepts and interventions. Ann Rev Pub Health 15:345-366
9. Drobes DJ, Tiffany ST (1997) Induction of smoking urge through imaginal and in vivo procedures: Physiological and self report manifestations. J Abnorm Psychol 106:15-25
10. Fagerström KO, Schneider NG, Lunnel E (1993) Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology 11:271-277
11. Fiore MC, Smith SS, Jorenby DE, Baker TB (1994) The effectiveness of the nicotine patch for smoking cessation: A meta-analysis. JAMA 271:1940-1947
12. Frederick SL, Reus VI et al (1998) Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers. Biol Psychiatry 43:525-530
13. Glassman AH, Jackson WK, Walsh BT, Roose SP, Rosenfield B (1984) Cigarette craving, smoking withdrawal, and clonidine. Science 226:864-866
14. Gritz ER, Carr CR, Marcus AC (1991) The tobacco withdrawal syndrome in unaided quitters. Br J Addict 86:57-69
15. Hughes JR (1992) Tobacco withdrawal in self-quitters. J Consult Clin Psychol 60:689-697
16. Hughes JR, Hatsukami DK, Pickens RW, Krahn D, Malin S, Luknic A (1984) Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology 83:82-87
17. Hughes JR, Higgins ST, Bickel WK (1994) Nicotine withdrawal versus other drug withdrawals syndromes: Similarities and dissimilarities Addiction 89:1461-1470
18. Kenford SL, Fiore CM, Jorenby DE, Smith SS, Wetter D, Baker TB (1994) Predicting smoking cessation. Who will quit with and without nicotine patches JAMA 2718:589-594
19. Killen JD, Fortmann SP (1997) Craving is associated with smoking relapse. Finding from three prospective studies. Exp Clin Psychopharmacol 5:137-142
20. Koch A, Hoffmann K, Steck W, Horsh A, Hengen N et al (1980) Acute cardiovascular reactions after cigarette smoking. Atherosclerosis 35:67-75
21. Jorenby DE, Hatsukami DK, Smith SS, Fiore MC, Allen S, Jensen J, Baker TB (1996) Characterization of tobacco withdrawal symptoms: Transdermal nicotine reduces hunger and weight gain. Psychopharmacology 128:130-138
22. Leischow SJ, Valente SN, Hill AL, Otte PS, Aickin M, Holden T, Kligman E, Cook G (1997) Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence. Exp Clin Psychopharmacol 5:54-64
23. Maude-Griffin PM, Tiffany ST (1996) Production of smoking urges through imagery: The impact of affect and smoking abstinence. Exp Clin Psychopharmacol 4:198-208
24. Omvik P(1996) How smoking affects blood pressure. Blood Press 5:71-77
25. Paten CA, Martin JE (1996) Does nicotine withdrawal affect smoking cessation? Clinical and theoretical issues. Ann Behav Med 18:190-200
26. Pickworth WB, Fant RV (1988) Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans. Psychoneuroendocrinology 23:131-141
27. Pickworth WB, Baumann MH et al (1996) Endocrine responses during acute nicotine withdrawal. Pharmacol Biochem Behav 55:433-437
28. Rose JE, Herskovic JE, Trilling Y, Jarvik ME (1985) Transdermal nicotine reduces cigarette craving and nicotine preference. Clin Pharmacol Ther 38:450-456
29. Schneider NG (1994) Smoker complaint scale (SCS), revised 1984. In: Kramer JJ et al (eds) 11th Mental Measurements Year Book. Buros Institute of Mental Measurements, Lincoln, pp 834
30. Schneider NG, Jarvik ME (1984) Time course of smoking withdrawal symptoms as a function of nicotine replacement. Psychopharmacology 82:143-144
31. Schneider NG, Jarvik ME, Forsythe AB (1984) Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation. Addict Behav 9:149-156
32. Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 30:35-39
33. Shiffman S, Engberg JB, Paty JA, Perz WG, Gnys M, Kassel JD, Hickcox M (1997) A day at a time: Predicting smoking lapse from daily urge. J Abnorm Psychol 106:104-116
34. The Transdermal Nicotine Study Group (1991) Transdermal nicotine for smoking cessation: Six-week results from two multicenter controlled clinical trials. JAMA 266:3133-3138
35. Tiffany ST, Drobes DJ (1991) The development and initial validation of a questionnaire on smoking urges. Br J Addict 86:1467-1476
36. Tiffany ST, Cox LS, Elash CA (2000) Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers. J Consult Clin Psychol 68:233-240
37. UNDCP, WHO (1992) Informal expert committee on the craving mechanism. Report United Nations International Drug Control Program and World Health Organization Technical Report Series V:92-54439T
38. Veldhuis JD (2000) Nature of alterated pulsatile hormone release and neuroendocrine network signalling in human ageing: Clinical studies of the somatotropic, gonadotropic, corticotropic and insulin axes. Novartis Found Symp 227:163-185
39. Wallace B, Pickworth, Fant RV (1998) Endocrine effects of nicotine administration: Tobacco and other drug withdrawal in human. Psychoneuroendocrinology 23:131-141
40. Zevin SJP, Benowitz NL (1998) Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther 64:87-95